This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 45/5/927    most recent 01.HYP.0000161873.27088.4cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rysä, J. Articles by Ruskoaho, H. Search for Related Content PubMed PubMed Citation Articles by Rysä, J. Articles by Ruskoaho, H. Pubmed/NCBI databases GEO DataSet GEO Profiles Medline Plus Health Information Heart Failure High Blood Pressure Related Collections Cardio-renal physiology/pathophysiology Animal models of human disease Hypertrophy Physiological and pathological control of gene expression

(Hypertension. 2005;45:927.)
© 2005 American Heart Association, Inc.

Original Articles

Distinct Upregulation of Extracellular Matrix Genes in Transition From Hypertrophy to Hypertensive Heart Failure

From the Department of Pharmacology and Toxicology (J.R., H.L., H.R.) and the Department of Physiology (M.I.), Biocenter Oulu, University of Oulu, Oulu, Finland.

Correspondence to Heikki Ruskoaho, MD, PhD, Department of Pharmacology and Toxicology, University of Oulu, P.O. Box 5000, FIN-90014 University of Oulu, Finland. E-mail heikki.ruskoaho{at}oulu.fi

Cardiac hypertrophy in response to pressure overload is initially beneficial but eventually leads to heart failure, a major cause of morbidity and mortality in the Western countries. Although abnormalities in left ventricular (LV) diastolic filling are early features associated with pressure overload-induced LV hypertrophy, the molecular mechanisms regulating transition to diastolic heart failure are poorly understood. We analyzed global changes in gene expression in 12-, 16-, and 20-month-old spontaneously hypertensive rats (SHR) and their age-matched controls, Wistar Kyoto rats, using DNA microarrays. In SHR, a progressive LV hypertrophy was associated with increased expression of hypertrophy-associated genes including contractile protein and natriuretic peptide genes. Echocardiography indicated that 16-month-old SHR had features of diastolic dysfunction leading to diastolic failure at age 20 months without significant changes in LV systolic function. Comparison analysis revealed that the extracellular matrix genes strikingly dominated the list of altered genes after transition to the heart failure, whereas there was no major shift in gene expression patterns involved in calcium homeostasis and neurohumoral activation, as well as myofilament contractile and cytoskeletal proteins. The microarray analysis also revealed differential gene expression of several novel factors, such as thrombospondin-4 and matrix Gla protein, as well as unknown expressed sequence tags. Our data show that transition from LV hypertrophy to diastolic hypertensive heart failure is almost exclusively associated with progressive remodeling of the extracellular matrix and provide new insights into the pathogenesis of hypertrophy by suggesting existence of novel regulators of LV remodeling.

Key Words: extracellular matrix • hypertension • hypertrophy • remodeling

This article has been cited by other articles:

				P. Rose, J. Bond, S. Tighe, M. J. Toth, T. L. Wellman, E. M. B. de Montiano, M. M. Lewinter, and K. M. Lounsbury Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, JunB, and CREB Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1075 - H1085. [Abstract] [Full Text] [PDF]

				F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF]

				Y. Chen-Izu, C. W. Ward, W. Stark Jr., T. Banyasz, M. P. Sumandea, C. W. Balke, L. T. Izu, and X. H. T. Wehrens Phosphorylation of RyR2 and shortening of RyR2 cluster spacing in spontaneously hypertensive rat with heart failure Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2409 - H2417. [Abstract] [Full Text] [PDF]

				O. I. Stenina, E. J. Topol, and E. F. Plow Thrombospondins, Their Polymorphisms, and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., September 1, 2007; 27(9): 1886 - 1894. [Abstract] [Full Text] [PDF]

				C. Cerutti, M. Kurdi, G. Bricca, W. Hodroj, C. Paultre, J. Randon, and M.-P. Gustin Transcriptional alterations in the left ventricle of three hypertensive rat models Physiol Genomics, November 21, 2006; 27(3): 295 - 308. [Abstract] [Full Text] [PDF]

				E. Bisping, S. Ikeda, S. W. Kong, O. Tarnavski, N. Bodyak, J. R. McMullen, S. Rajagopal, J. K. Son, Q. Ma, Z. Springer, et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure PNAS, September 26, 2006; 103(39): 14471 - 14476. [Abstract] [Full Text] [PDF]

				M. Brancaccio, E. Hirsch, A. Notte, G. Selvetella, G. Lembo, and G. Tarone Integrin signalling: The tug-of-war in heart hypertrophy Cardiovasc Res, June 1, 2006; 70(3): 422 - 433. [Abstract] [Full Text] [PDF]

				A. M. Deschamps and F. G. Spinale Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation Cardiovasc Res, February 15, 2006; 69(3): 666 - 676. [Abstract] [Full Text] [PDF]